Search

everythinglearnresearchcommunity

for

Search:↓

Bedaquiline, Telmisartan, Diosmin, Azelastine, and Adapalene may be effective treatments for onchocerciasis.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Drug repositioning offers a cost-effective, lower-risk way to treat diseases and pandemics like COVID-19.

Adapalene, Diosmin, and Azelastine may effectively treat onchocerciasis.

Adapalene, Diosmin, and Azelastine may effectively treat onchocerciasis.

Adapalene, Diosmin, and Azelastine could be repurposed to treat onchocerciasis.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Certain drugs like Dutasteride and Finasteride might help fight SARS-CoV-2 by increasing levels of a steroid called DHEA, which can protect the heart and increase nitric oxide to counteract the virus.

Skin reactions to drugs are most often rashes caused by antibiotics, with nevirapine being the most common culprit; knowing these patterns can improve treatment and outcomes.

Tangent screens help detect visual field defects from vigabatrin.

New topical antifungals and delivery systems are improving treatment for fungal skin infections, but patient education and prevention are key.

Imuvert can prevent some chemotherapy-induced hair loss.

The extract from the plant Adiantum capillus-veneris might be used to treat COVID-19.

Interferon α‐2b can temporarily reduce hepatitis C virus and normalize liver enzyme levels.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

AVT is highly conserved and may have antimicrobial properties.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

Lamivudine might reverse hair graying and needs more research for potential treatments.

Hepatitis B virus alters steroid hormones in male mice, reducing dihydrotestosterone to inhibit viral replication.

Topical Vorinostat shows promise for treating alopecia areata by promoting hair regrowth.

New isatin-gallate hybrids show promise as antioxidants, cancer treatments, and coronavirus inhibitors.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Avacopan may cause unexpected side effects, so early monitoring is important.

Infectious virus was not found after the third remdesivir dose, suggesting early end of isolation is possible.

Low power red laser with efavirenz can reduce HIV-1 infection to undetectable levels and improve diagnosis.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

A woman lost all her body hair after hepatitis C treatment, but it started to grow back a year after stopping the treatment.